Discovery
Scribe takes USD 25m in CIRM funding to push CRISPR CVD programs into clinic
Scribe Therapeutics has received more than USD 25 million from the California Institute for Regenerative Medicine (CIRM) to advance two preclinical...
Oligomerix picks up NIH grant to push oral tau inhibitor into clinic for Alzheimer's
Oligomerix, a clinical-stage biotechnology company based at the Albert Einstein College of Medicine in the Bronx, New York, has received a USD 1.9 million...
Michael J. Fox Foundation backs Neuron23's LRRK2 trial expansion into Israel
South San Francisco-based Neuron23 has received a USD 2.5 million grant from The Michael J. Fox Foundation for Parkinson's Research to expand its NEULARK...
NIDA renews support for Northeastern cannabinoid drug discovery program
Northeastern University has received a USD 1.43 million NIDA P01 program project renewal to advance structure-guided drug discovery targeting CB1 and CB2...
Rutgers researchers explore PARP1 inhibition as strategy against chemotherapy-related cognitive impairment
Rutgers Biomedical and Health Sciences has received a USD 1.78 million National Cancer Institute R01 award to identify biomarkers and evaluate therapeutic...
UCSF explores molecular drivers of pulmonary veno-occlusive disease
University of California, San Francisco has received a USD 1.63 million NIH R01 grant from the National Heart, Lung, and Blood Institute to investigate the...
Mayo Clinic expands multi-ethnic blood biomarker effort for Alzheimer's disease
Mayo Clinic Jacksonville has received a USD 8.16 million National Institute on Aging U19 renewal grant to advance blood-based biomarker discovery for...
Columbia investigates HPF1's role in PARP inhibitor bone marrow toxicity
Columbia University Health Sciences has received a USD 1.83 million NIH R01 grant from the National Cancer Institute to investigate how Histone PARylation...
Fred Hutch investigates how Par-4 eliminates dormant breast cancer cells
Fred Hutch Cancer Center has received a USD 1.8 million NCI R01 renewal to investigate how the tumor suppressor Par-4 regulates actomyosin contractility as...
University of Illinois advances multivalent ETEC vaccine designed to target both toxins and adhesins
University of Illinois Urbana-Champaign has received a USD 1.12 million NIAID R01 grant to advance MecVax, a multivalent subunit vaccine candidate targeting...
NIH funds Michigan State Uni study for antibody-switching mechanism linked to B cell lymphoma
Henry Ford Health + Michigan State University Health Sciences has received a USD 2.86 million NIH R01 grant from the National Institute of Allergy and...
Cognision research points to baseline EEG signature guiding to hidden responder groups in ketamine challenge studies
Researchers at Louisville, Kentucky-based Cognision (Nasdaq: not listed), working through the EEG/ERP Biomarker Qualification Consortium, report that an...
KAIST, Chungnam National Uni use organoid platform to identify lazertinib's utility in glioblastoma
A functional drug-screening platform built on patient-derived glioblastoma organoids predicted individual patient responses to temozolomide more accurately...
Dana-Farber Cancer Institute receives USD 50m Yawkey Foundation grant for Boston hospital
Dana-Farber Cancer Institute has received a USD 50 million philanthropic grant from the Yawkey Foundation to support construction of a planned 300-bed...
University of Minnesota wins NIH support for CAR Treg and lipid nanoparticle cGVHD therapies
The University of Minnesota has received a USD 1.58 million NIH R01 grant from the National Heart, Lung, and Blood Institute to investigate the cellular...
The AllSci Brief
Systematic R&D and deal news. Daily.